Cargando…

Evaluating the intracranial activity of adagrasib

Detalles Bibliográficos
Autores principales:	Kotecha, Rupesh, La Rosa, Alonso, Kutuk, Tugce, Ahluwalia, Manmeet S., Mehta, Minesh P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183405/ https://www.ncbi.nlm.nih.gov/pubmed/37197630 http://dx.doi.org/10.21037/tlcr-23-74

Ejemplares similares

Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas
por: La Rosa, Alonso, et al.
Publicado: (2023)

Recent advances in managing brain metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2018)

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
por: Tonse, Raees, et al.
Publicado: (2021)

Is adagrasib just another sotorasib?—or, should we differentiate their usage according to patients’ clinical presentation?
por: Oya, Yuko, et al.
Publicado: (2023)

NEIM-02 CHARACTERIZATION OF LARGE BRAIN METASTASES WITH(18)F-FLUCICLOVINE PET/CT TREATED WITH STAGED STEREOTACTIC RADIOSURGERY (SSRS): INTERIM ANALYSIS OF A PILOT STUDY
por: Rosa, Alonso La, et al.
Publicado: (2023)

Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results
por: Kutuk, Tugce, et al.
Publicado: (2022)

Zero Setup Margin Mask versus Frame Immobilization during Gamma Knife(®) Icon™ Stereotactic Radiosurgery for Brain Metastases
por: Kutuk, Tugce, et al.
Publicado: (2022)

Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases
por: La Rosa, Alonso, et al.
Publicado: (2023)

Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data
por: Kutuk, Tugce, et al.
Publicado: (2022)

RADI-11. Evaluating the Tissue Effects of Dose-escalated Pre-operative Stereotactic Radiotherapy for Resectable Brain Metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2021)

OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance
por: Tonse, Raees, et al.
Publicado: (2021)

Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis
por: Tonse, Raees, et al.
Publicado: (2021)

Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance
por: Tonse, Raees, et al.
Publicado: (2021)

Adagrasib: A landmark in the KRAS(G12C)‐mutated NSCLC
por: Tian, He, et al.
Publicado: (2022)

Editorial: Effects of radiation therapies on brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2023)

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh P, et al.
Publicado: (2020)

TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh, et al.
Publicado: (2019)

CLRM-10 METIS (EF-25): A PIVOTAL, RANDOMIZED CONTROLLED STUDY OF TUMOR TREATING FIELDS IN PATIENTS WITH 1–10 BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
por: Mehta, Minesh, et al.
Publicado: (2022)

Hospitalization rates from radiotherapy complications in the United States
por: Tonse, Raees, et al.
Publicado: (2022)

Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States
por: Tonse, Raees, et al.
Publicado: (2021)

A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib
por: Brazel, Danielle, et al.
Publicado: (2022)

Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2022)

Brain metastasis and treatment
por: Ahluwalia, Manmeet S., et al.
Publicado: (2014)

Synthesis of Adagrasib (MRTX849), a Covalent KRAS(G12C) Inhibitor Drug for the Treatment of Cancer
por: Chen, Cheng-yi, et al.
Publicado: (2023)

Update on the Management of Brain Metastasis
por: Singh, Karanvir, et al.
Publicado: (2022)

Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS(G12C)-Mutated Non–Small-Cell Lung Cancer Who Have Untreated CNS Metastases
por: Negrao, Marcelo V., et al.
Publicado: (2023)

Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo
por: Zhang, Yuchen, et al.
Publicado: (2022)

Idiopathic Intracranial Hypertension- The Eyes and Beyond
por: Ray, Sucharita, et al.
Publicado: (2022)

33. SYSTEMATIC REVIEW AND META-ANALYSIS OF BREAST CANCER BRAIN METASTASIS AND PRIMARY TUMOR RECEPTOR EXPRESSION DISCORDANCE
por: Kotecha, Rupesh, et al.
Publicado: (2020)

Intracranial Atherosclerosis Disease: A Preventable Epidemic
por: Moonis, Majaz
Publicado: (2020)

Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Evaluating the performance of health promotion interventions
por: Kaur, Manmeet, et al.
Publicado: (2015)

SPIN-01 RADIATION THERAPY ALONE VERSUS RADIATION THERAPY PLUS RADIOFREQUENCY ABLATION/VERTEBRAL AUGMENTATION FOR SPINE METASTASIS: TRIAL IN PROGRESS
por: Kotecha, Rupesh, et al.
Publicado: (2022)

Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy(10) for Non-bone Oligometastases
por: Kutuk, Tugce, et al.
Publicado: (2022)

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets
por: Ozair, Ahmad, et al.
Publicado: (2023)

Utility of Stapedial Reflex in Idiopathic Intracranial Hypertension: The Proof is in the Pudding
por: Prakash, Sanjay, et al.
Publicado: (2022)

Practical Guidance for the Management of Adverse Events in Patients with KRAS(G12C)-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib
por: Zhang, Jun, et al.
Publicado: (2023)

Current understanding of role of venous sinus stenosis in management of idiopathic intracranial hypertension
por: Muzumdar, D
Publicado: (2023)

Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRAS(G12C)-Mutant Non–Small Cell Lung Cancer
por: Sabari, Joshua K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0pqcughfup4gjni44j0lqiur67